› 6ak4

X-ray diffraction
2.8Å resolution

Crystal structure of human FTO in complex with small-molecule inhibitors

Released:
DOI: 10.2210/pdb6ak4/pdb
PDB entry 6ak4 coloured by chain, front view.
PDB entry 6ak4 coloured by chain, side view.
PDB entry 6ak4 coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1.
Peng S, Xiao W, Ju D, Sun B, Hou N, Liu Q, Wang Y, Zhao H, Gao C, Zhang S, Cao R, Li P, Huang H, Ma Y, Wang Y, Lai W, Ma Z, Zhang W, Huang S, Wang H, Zhang Z, Zhao L, Cai T, Zhao YL, Wang F, Nie Y, Zhi G, Yang YG, Zhang EE, Huang N
Sci Transl Med 11 (2019)
PMID: 30996080

Function and Biology Details

Reaction catalysed: 
N(6)-methyladenosine in mRNA + 2-oxoglutarate + O(2) = adenosine in mRNA + formaldehyde + succinate + CO(2)
Biochemical function:
Biological process:
Cellular component:
  • not assigned
Sequence domains:

Structure analysis Details

Assembly composition:
monomeric (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-189888 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Alpha-ketoglutarate-dependent dioxygenase FTO Chain: A
Molecule details ›
Chain: A
Length: 470 amino acids
Theoretical weight: 54.12 KDa
Source organism: Homo sapiens
Expression system: Escherichia coli
UniProt:
  • Canonical: Q9C0B1 (Residues: 32-159, 186-505; Coverage: 89%)
  • Best match: Q9C0B1-4 (Residues: 1-106)
Gene names: FTO, KIAA1752
Sequence domains:

Ligands and Environments

2 bound ligands:
Ligand ZN 1 x ZN
Ligand PD9 1 x PD9
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: SSRF BEAMLINE BL17U
Spacegroup: R3
Unit cell:
a: 141.77Å b: 141.77Å c: 83.751Å
α: 90° β: 90° γ: 120°
R-values:
R R work R free
0.211 0.209 0.253
Expression system: Escherichia coli

Quick links

Citations

83 review citations

The role of m6A RNA methylation in human cancer.
Chen et al. (2019)
82 more

5 mentions without citation

Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
You et al. (2022)
4 more